RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk
Karin Tobin, Melissa A Davey-Rothwell, Bareng A S Nonyane, Amy Knowlton, Lawrence Wissow, Carl A Latkin, Karin Tobin, Melissa A Davey-Rothwell, Bareng A S Nonyane, Amy Knowlton, Lawrence Wissow, Carl A Latkin
Abstract
Depression and depressive symptoms mediate the association between drug use and HIV risk. Yet, there are few interventions that target depressive symptoms and HIV risk for people who use drugs (PWUD). This study was a randomized controlled trial of an integrated cognitive behavioral therapy and HIV prevention intervention to reduce depressive symptoms, injection risk behaviors and increase condom use in a sample of urban people who used heroin or cocaine in the prior 6 months. A total of 315 individuals aged 18-55, who self-reported at least one HIV drug and sex risk behavior and scored ≥16 and <40 on the Centers for Epidemiologic Studies-Depression (CES-D) scale were randomized using a two-block design, stratified by sex to ensure equivalent numbers, to a 10 session intervention arm (n = 162) or a single session control arm (n = 153). The outcomes of interest were decreases in CES-D score and injection risk behaviors and increases in condom use. The sample was majority African American (85%) and unemployed (94%). Nearly half (47%) reported injection in the prior 6 months and only 19% were taking medication for depression. Follow-up assessments were conducted at 6 and 12 months. Retention at 12 months was 94%. Intervention arm was associated with statistically significantly lower CES-D score at 12 month compared to control. No differences were observed between arms in injection risk. At 6 month, intervention was associated with greater odds of condom use with non-main partner. These findings suggest the potential role of the integrated intervention in reducing depressive symptoms, but weak impact on HIV risk. This trial is registered with ClinicalTrials.gov under the title "Neighborhoods, Networks, Depression, and HIV Risk" number NCT01380613.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Lansky A, Finlayson T, Johnson C, Holtzman D, Wejnert C, Mitsch A, et al. Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One. 2014;9: e97596 doi:
- Spiller MW, Broz D, Wejnert C, Nerlander L, Paz-Bailey G, Centers for Disease Control and Prevention (CDC), et al. HIV infection and HIV-associated behaviors among persons who inject drugs—20 cities, United States, 2012. MMWR Morb Mortal Wkly Rep. 2015;64: 270–275.
- Conner KR, Pinquart M, Duberstein PR. Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction. 2008;103: 524–534. doi:
- Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression severity and drug injection HIV risk behaviors. Am J Psychiatry. 2003;160: 1659–1662. doi:
- Hides L, Samet S, Lubman DI. Cognitive behaviour therapy (CBT) for the treatment of co-occurring depression and substance use: current evidence and directions for future research. Drug Alcohol Rev. 2010;29: 508–517. doi:
- Watkins KE, Hunter S, Hepner K, Paddock S, Zhou A, de la Cruz E. Group cognitive-behavioral therapy for clients with major depression in residential substance abuse treatment. Psychiatr Serv. 2012;63: 608–611. doi:
- Hunter SB, Watkins KE, Hepner KA, Paddock SM, Ewing BA, Osilla KC, et al. Treating depression and substance use: a randomized controlled trial. J Subst Abuse Treat. 2012;43: 137–151. doi:
- Hides L, Carroll S, Catania L, Cotton SM, Baker A, Scaffidi A, et al. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people. J Affect Disord. 2010;121: 169–174. doi:
- Centers for Disease Control and Prevention. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men—five U.S. cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep. 2005;54: 597–601.
- Centers for Disease Control and Prevention. Prevalence and awareness of HIV infection among men who have sex with men—21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59: 1201–1207.
- Eaton WW, Muntaner C, Smith C, Tien A, Ybarra M. Center for Epidemiologic Studies Depression Scale: Review and Revision (CESD and CESD-R). In: Erlbaum L, editor. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. Mahwah, NJ; 2004. pp. 363–377.
- Hawkins WE, Latkin C, Green DL. Depression therapy with injection drug users: results of a pilot study. Am J Drug Alcohol Abuse. 2005;31: 243–251.
- Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into Action study: A peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011;106: 366–375. doi:
- Davey-Rothwell MA, Tobin K, Yang C, Sun CJ, Latkin CA. Results of a randomized controlled trial of a peer mentor HIV/STI prevention intervention for women over an 18 month follow-up. AIDS Behav. 2011;15: 1654–1663. doi:
- Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1: 385–401.
- Radloff LS, Locke BZ. The community mental health assessment survey and the CES-D scale In: Weissman MM, Myers JL, Ross CE, editors. Community surveys of psychiatric disorder. New Brunswick, NJ: Rutgers University Press; 1986. pp. 177–189.
- Zimmerman M, Coryell W. The validity of a self-report questionnaire for diagnosing major depressive disorder. Arch Gen Psychiatry. 1988;45: 738–740.
- Boyd JH, Weissman MM, Thompson WD, Myers JK. Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic scales. Arch Gen Psychiatry. 1982;39: 1195–1200.
- Munoz RF, Mendelson T. Toward evidence-based interventions for diverse populations: The San Francisco General Hospital prevention and treatment manuals. J Consult Clin Psychol. 2005;73: 790–799. doi:
- Tsai AC, Mimiaga MJ, Dilley JW, Hammer GP, Karasic DH, Charlebois ED, et al. Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. AIDS Behav. 2013;17: 2765–2772. doi:
- Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379: 55–70. doi:
- Cuijpers P, Munoz RF, Clarke GN, Lewinsohn PM. Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later. Clin Psychol Rev. 2009;29: 449–458. doi:
- Osilla KC, Hepner KA, Munoz RF, Woo S, Watkins K. Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy. J Subst Abuse Treat. 2009;37: 412–420. doi:
- Safren SA, O'Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80: 404–415. doi:
Source: PubMed